Ansbert Gadicke - 16 Sep 2021 Form 4 Insider Report for Cullinan Oncology, Inc. (CGEM)

Role
Director, 10%+ Owner
Signature
/s/ Jeffrey Trigilio, Attorney-in-Fact
Issuer symbol
CGEM
Transactions as of
16 Sep 2021
Transactions value $
$0
Form type
4
Filing time
25 Mar 2022, 19:32:26 UTC
Previous filing
16 Sep 2021
Next filing
23 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGEM Stock Option (Right to Buy) Award $0 +7.8K $0.00 7.8K 16 Sep 2021 Common Stock 7.8K $28.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option represents a right to purchase a total of 7,800 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 25, 2022 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date.